We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Their unique adiposet system dramatically improves the patient experience of breast reconstruction following breast cancer treatment, whilst improving clinical practice and reducing cost to NHS and private hospitals. Adiposet also has applications in many other therapeutic and cosmetic procedures.
days to go: Expired investment: £446,380
Baanx is a B2B2C mobile banking platform offering cutting-edge services in remittance, spending & blockchain. The company takes pride in its innovative customer acquisition process through partner communities. The BaanxCL already has a CL™ VISA Debit Card, Crypto-Payment Gateway, a Crypto-Exchange, Stablecoins, and other exciting features. The company is also partnering with new brands around the world which are not banking already but have large user communities to connect. The company is aiming to target 100,000 users by Q2 2020 with the assistance of Super Seed Investors. With the proceeds, Baanx will hire additional team members, spend funds on marketing, and launch services in South America and Asia.

Pitch Rated

49%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £658,200
An online estate agent with a mission to be honest, reliable and friendly to clients who wish to sell their properties, along with offering money back guarantees. eSale is gaining popularity across England and Wales due to its strong USPs with increased instructions of 247% compared to 2017 and has recently entered the Scottish property market.
days to go: Expired investment: £3,219
Spendology is a fintech company that licenses a digital-first SaaS-based travel money platform to retailers globally, addressing the demand for travel cash, which remains popular among Brits, with over £56 billion spent annually. Inspired by the inconvenience of traditional currency exchange services, the company's chairman, Don Clark, aims to revolutionize the industry, much like he did in a previous financial services venture that resulted in a significant sale. Spendology's innovative platform allows travel companies to offer online ordering and home delivery of travel cash, generating additional profits for these businesses and royalties for Spendology. Their platform is available to travel companies of all sizes worldwide, already operating in the UK and launching in the US, with plans to expand to 28 countries, serving a market worth $1 trillion.
days to go: Expired investment: £354,053
Cloud-based SaaS software with the purpose of efficiently generating corporate management reports to reduce operational costs and improve data quality. Synapse's service can be implemented into pre-existing financial reporting systems to produce automated reports, even in large companies. Customers include Lloyds Bank, who have signed a 2-year term and the Bank of England have contacted Synapse to potentially integrate the system.
days to go: Expired investment: £894,056
dooo is an all-inclusive platform that offers on-demand specialised home haircut service to consumers. The company claims that 21% of people reported a disability in the UK in 2018 and 49% of people reported social anxiety or other mental health issues, that prevented them from visiting a salon. dooo wants to change this by helping everyone get the haircut they want, wherever they want and overcome the inequalities in the hair industry. dooo allows users to connect with the stylist beforehand and express any special requests to tailor the experience to their requirements. The company aims to become a contender in the 'Hair & Beauty industry that generated over £8 billion in 2018 in the UK alone. dooo will use the investment to develop native mobile apps on both iOS and Android, boost marketing and PR strategies to further its 'Bristol Launch' in Summer 2021, pay wages to essential staff, and manage administrative tasks.

Pitch Rated

75%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £70,850
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph